IP Library Granted Patent US 9,028,887
Granted Patent B2
US 9,028,887 · App. 14/284,901 · Granted May 12, 2015

Method improve spatial memory via pterostilbene administration

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,028,887
App. No.
14/284,901
Granted
May 12, 2015
Kind
B2
Abstract

Disclosed is a pharmaceutical composition for treating oxidative stress comprising a therapeutically effective amount of a substantially pure compound of pterostilbene and a physiologically acceptable carrier. Pterostilbene is administered in an amount between about 2.5 mg to about 10 mg per kilogram of subject body weight. Also disclosed is a method for increasing a working memory of a subject, the method comprising administrating an effective amount of a substantially pure compound of pterostilbene, wherein the working memory for a subject increase and the therapeutic effectiveness is about 10 mg of pterostilbene per kilogram of subject body weight.

Claims (7)

1. A method for increasing the spatial learning of a subject, the method comprising administrating to a subject in need thereof an effective amount of isolated or purified pterostilbene, wherein the spatial learning for a subject is increased.

2. The method as recited in claim 1 wherein the effective amount of isolated or purified pterostilbene is about 10 mg of compound per kilogram of subject body weight.

3. The method of claim 1 wherein pterostilbene is administered with a pharmaceutical carrier.

4. The method of claim 1 wherein pterostilbene is administered with a nutraceutical carrier.

5. The method of claim 1 wherein the effective amount of isolated or purified pterostilbene is an amount about 2.5 mg to about 10 mg of compound per kilogram of subject body weight.

6. The method of claim 1 wherein the subject is afflicted with a neurodegenerative disease.

7. The method of claim 6 wherein the neurodegenerative disease is Alzheimer's disease.

Assignments (1)
SECURITY INTEREST Recorded Nov 11, 2016
From: CHROMADEX, INC.
To: WESTERN ALLIANCE BANK
Reel/Frame 040291/0873 →